10x Genomics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
10x Genomics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2018 to Q2 2024.
  • 10x Genomics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $4.66M, a 79.8% increase year-over-year.
  • 10x Genomics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $20M, a 72.8% increase year-over-year.
  • 10x Genomics, Inc. annual Nonoperating Income (Expense) for 2023 was $16.6M, a 177% increase from 2022.
  • 10x Genomics, Inc. annual Nonoperating Income (Expense) for 2022 was $5.97M.
  • 10x Genomics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.46M, a 338% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $20M $4.66M +$2.07M +79.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $17.9M $3.7M +$1.36M +58.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $16.6M $8.59M +$1.91M +28.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $14.7M $3.05M +$3.09M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $11.6M $2.59M +$3.31M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $8.27M $2.33M +$2.29M +5593% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $5.97M $6.69M +$6.85M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 -$875K -$39K +$730K +94.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$1.61M -$714K -$1.08M -293% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$521K $41K +$941K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$1.46M -$163K -$1.12M -117% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 -$339K -$769K -$761K -9513% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $422K $370K +$695K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$273K -$900K +$61K +6.35% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$334K $960K -$94K -8.92% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 -$240K -$8K +$491K +98.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$731K -$325K +$123K +27.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$854K -$961K -$394K -69.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$460K $1.05M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 -$499K -$103K -26% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$448K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$567K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 -$396K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.